Brinzolamide

Brinzolamide
Product Description

MKPPL developed a Nano particle based matrix which can deliver hydrophilic as well as hydrophobic drugs using a combination of hydrophilic and hydrophobic excipients as a clear solution. This cogent use of excipients ensures that the drug is absorbed optimally and the Nano particles ensure that the drug penetrates not only through the hydrophobic and hydrophilic channels but also through the OraSerrata which protects the eye from any foreign body entering the optical cavity.

Read more Show less

Murli Krishna Pharma Pvt. Ltd.

  • IN
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
Custom Manufacturing/Custom Synthesis
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    India
More specifications Fewer specifications

Murli Krishna Pharma Pvt. Ltd.

  • IN
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
Custom Manufacturing/Custom Synthesis
View company profile

More Products from Murli Krishna Pharma Pvt. Ltd. (27)

  • CLARITHROMYCIN MICRO PELLETS 27.5%W/W :(CLARITHROMYCIN Enteric Coated pellets 27.5%w/w)

    Product CLARITHROMYCIN MICRO PELLETS 27.5%W/W :(CLARITHROMYCIN Enteric Coated pellets 27.5%w/w)

    Physical Specifications: White to off white spherical pellets, Pellets Size: ASTM 30#80. Release specification: As per latest USP std, including additional parameters i.e. Related Substances (RS/impurities) and Microbiological (Ready To Fill size 0 Capsule, for Hard Gelatin Capsule ...
  • ITRACONAZOLE PELLETS 22% W/W:

    Product ITRACONAZOLE PELLETS 22% W/W:

    ITRACONAZOLE PELLETS 22% W/W:

    Specifications: White to off white spherical pellets,
    Pellets Size:  ASTM16#20: 
    Release specification: As per latest USP std.
    Fill Weight: 
    For 100mg capsule: 455mg pellets filled in SIZE 0 capsules. 1 kg of Pellets can ...
  • LANSOPRAZOLE Micro PELLETS 12.5%W/W: (Lansoprazole Enteric Coated Micro pellets 12.5%)

    Product LANSOPRAZOLE Micro PELLETS 12.5%W/W: (Lansoprazole Enteric Coated Micro pellets 12.5%)

    LANSOPRAZOLE Micro PELLETS 12.5%W/W: (Lansoprazole Enteric Coated Micro pellets 12.5%)

    Physical Specifications: White to off while spherical pellets, Pellets Size: ASTM 30#50, ASTM 25#50

    Release specification: As per latest USP std. including additional parameters i.e. ...
  • Lansoprazole Pellets 8.5%

    Product Lansoprazole Pellets 8.5%

    We Murli Krishna Pharma specialised in the manufacture of Pharmaceutical Pellets/ Micro Pellets / Granules and MUPS.We manufacture Lansoprazole Pellets 8.5%( Product complies to USP) Particle size:  ( 14 #18), ( 16 #20) and ( 30 #80) Comparative Dissolution:  The profile matches...
  • Omeprazole PELLETS 8.5%W/W: (OmeprazoleEnteric Coated pellets 8.5%w/w)

    Product Omeprazole PELLETS 8.5%W/W: (OmeprazoleEnteric Coated pellets 8.5%w/w)

    Omeprazole PELLETS 8.5%W/W: (OmeprazoleEnteric Coated pellets 8.5%w/w)


    Physical Specifications: 

    White to off while spherical pellets, Pellets Size: ASTM 14#18.

    Release specification: As per latest USP std. including additional parameters i.e. Related...
  • Azithromycin Taste Masked Pellets

    Product Azithromycin Taste Masked Pellets

    The objective of developing Azithromycin taste masked micro pellets (Multiple unit particulate system i.e. MUPS) by aqueous technology is to fill the micro pellets in to capsule, are compressed into tablet and also are constituted to make the oral suspension.
  • Budesonide

    Product Budesonide

    There is a potential for the development of inhalation medicines in lipid Nano particles to possess controlled release properties. MKPPL’s Budesonide suspension has been developed in a complete aqueous base using a couple of specialized solubilizers which also helps in the Nano encapsulation of the drug.
  • Dexlansoprazole Pellets

    Product Dexlansoprazole Pellets

    The pharmaceutical form of dexlansoprazole is based on the unique technology of modified dual release. The active ingredient is released in two phases at different pH values and with a time interval. Consequently, the drug achieves two peak concentrations in the blood, and the total serum concentration...
  • Duloxetine

    Product Duloxetine

    The objective is to develop Duloxetine DR pellets by aqueous technology. Pellets developed by aqueous technology have advantage of avoiding the use of organic solvents
  • Erlotinib MUPS, Granules

    Product Erlotinib MUPS, Granules

    Murli Krishna Pharma developed a Nano particle based premix for direct compression into tablets. The premix was developed using the following approach: 1)            Enhance the solubility of Erlotinib at near neutral pH. 2)  ...
  • Esomeprazole MUPS 22.5%

    Product Esomeprazole MUPS 22.5%

    MUPS have distinct advantages over single unit system such as multiple unit particles get distributed throughout the GI tract thereby avoiding localized accumulation. MUPS developed by aqueous technology have also advantage of avoiding the use of organic solvents.
  • Everolimus Micro Pellets

    Product Everolimus Micro Pellets

    MKPPL is the first to come up with Pellet based approach for Immune Suppressants.  Our pellet based approach reduces the variability of absorption of “LIMUS” based immune suppressants owing to smoother and uniform surface of the particles.
show all 27 other products

Murli Krishna Pharma Pvt. Ltd. resources (1)